Delivery Order SPE2DB22D3501-SPE2DB25FUD99

Award Date 1/15/25
Potential Completion Date 1/16/25
Potential Value $9.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DB22D3004|SPE2DB25FNS13, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, with a ceiling value of $8,350.28, is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product. The contract type is Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of December 5, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award, with the ID SPE2DB24D2010|SPE2DB25FZSX8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. It is a firm fixed-price delivery order contract with a ceiling value of $11,209.90 and an ultimate completion date of November 25, 2024. The contract does not have a set-aside designation, indicating an open competition....
This federal contract award, with ID SPE2DB22D3019|SPE2DB24FK3QP, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $24,804.57, for the supply of TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical products. The contract has an ultimate completion date of July 25, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a...
This federal contract award, with an ID of SPE2DB20D1100|SPE2DB25FZ92T, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,707.94, is a delivery order for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 7, 2025. This award is not designated as a...
The federal contract award, with ID SPE2DB20D2104|SPE2DB25FMBWQ, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,815.12 firm fixed-price delivery order is for the provision of TRELEGY ELLIPTA 100-62.5-25 60S medication. The contract has an ultimate completion date of November 14, 2024 and is not designated as a set-aside award. AmerisourceBergen Drug Corp holds a significant $999,999,999...
This federal contract award, with the ID SPE2DB20D2104|SPE2DB25FMHZA, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,967.87 firm fixed-price delivery order is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a completion date of February 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DB20D3103|SPE2DB25FM9E1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,678.57 firm fixed-price delivery order is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of March 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with an ID of SPE2DB22D3501|SPE2DB25FUQ24, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award, valued at $26,292.50, is for the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. It is a Firm Fixed Price Delivery Order contract with a completion date of February 20, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
This federal contract award, with ID SPE2DB22D2009|SPE2DB25FL6NE, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,658.12 firm-fixed-price delivery order is for the medication TRELEGY ELLIPTA 100-62.5-25 60S. The contract has a completion date of November 20, 2024 and was awarded on November 19, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, with ID SPE2DB20D3505|SPE2DB24FT4Z5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,218.93 delivery order contract is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of December 21, 2023. This award is associated with a larger Indefinite Delivery...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FUD99
    Delivery Order

This federal contract award, with an ID of SPE2DB22D3501|SPE2DB25FUD99, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $9,798.79, is a Firm Fixed Price Delivery Order for the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S. The contract has an ultimate completion date of January 16, 2025 and was awarded on January 15, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/21/25, 10:15 AM